The Nigeria Centre for Disease Control has confirmed the outbreak of measles in eight states of the federation.
The NCDC via its official website on Friday said that the eight states affected were; Jigawa, Anambra, Katsina, Rivers, Enugu; Delta, Osun and Sokoto, which had 908 suspected cases had been reported so far.
The News Agency of Nigeria reports that measles is a very contagious infection caused by a virus, and it is common among children.
The main symptoms of measles are red-brown blotchy rashes and cold-like symptoms.
Measles is spread through coughs and sneezes and is usually contracted before the symptoms fully develop.
The public health agency also stated that there was an ongoing outbreak of measles in Zamfara, which had not been confirmed due to the absence of testing reagents.
It was reported that 58.7 per cent of confirmed cases were those that had not been vaccinated, the agency added that as of 2021, a total of 15,792 suspected cases were reported across 683 local government areas across the country.
“So far this year, a total of 908 suspected cases have been reported in 29 states and the Federal Capital Territory.
“Thirteen LGAs across eight states have recorded an outbreak of measles in 2022. The states are Jigawa, Katsina, Rivers, Enugu, Anambra, Delta, Osun and Sokoto.
“There is an ongoing outbreak of suspected measles cases in Zamfara, but this is awaiting confirmation due to lack of its testing kits in the country.
“Borno, Jigawa, Katsina, Kebbi, Kwara and Anambra accounted for 55.2 per cent of the 908 suspected cases reported so far. Up to 58.7 per cent of the confirmed cases have not received a dose of measles vaccine,” it explained.
The NCDC stated that 100 per cent of cases recorded in Jigawa, Sokoto, Enugu and Katsina were not vaccinated.
The agency also said that 54.4 per cent were not vaccinated in Borno; 50 per cent in Akwa Ibom; 66.7 per cent in Delta; 50 per cent in Ekiti; 25 per cent in Lagos; 83.3 per cent in Osun; 8.3 per cent in Oyo; and 50 per cent in Rivers.
“Of the 908 suspected cases reported, 88 were laboratory confirmed, 166 clinically compatible, 148 were discarded and 506 are pending classification,” it added.
